ARCHIVES

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

This article is from The Cancer Letter archive.

Vol. 01 No. 30 | July 25, 1975

Download PDF Visit The Full Archive

Related Articles

Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent.

February 24, 2006

In Brief: Willis Taylor New ACS President, Gerald Murphy President Elect, Robert Gadberry Bord Chairman

November 19, 1982

GAO Eppley Report Offers Lessons for Grantees, Contractors

March 3, 1978

In Brief: Margaret Holms Names Centers Branch Chief; Kimes To Recruit As Special Assistant

March 30, 1990

US Oncology Renegotiates Affiliations, Converts Practices To Earnings Model.

November 30, 2001

FDA Issues Final Rules On Patient Access To Investigational Drugs

September 11, 2009